Labetalol Hydrochloride Injection, Solution
Product Images NDC 72603-146

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Labetalol Hydrochloride (NDC 72603-146). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rx Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Labetalol Hydrochloride Carton)

FDA Label Image

Vial (Labetalol Hydrochloride Vial)

Vial (Labetalol Hydrochloride Vial)
This is a description of Labetalol Hydrochloride injection which is available in a 100 mg/20mL multiple-dose vial for intravenous injection only. Each mL contains 5 mg of labetalol hydrochloride USP, 45 mg anhydrous dextrose, 0.10 mg edetate disodium, and other components like citric acid, sodium hydroxide, methylparaben, and propylparaben. Usual adult dosage and administration routes are provided in the package insert. It is advised to store it at 20°C to 25°C and protect it from freezing and light. This injection should be discarded after the mentioned date. The manufacturer is Northstar Rx LLC, Memphis, TN while it is manufactured by Caplin Steriles Limited, India.*
FDA Label Image

Structure (Labetalol Spl Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.